Clinical Trial Update: A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS) [Phase 2]

View source ↗

Summary

A Phase 2 study investigating GW427353 in irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• GW427353 (GW427353)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Irritable Bowel Syndrome (IBS) | Phase 2 | Status: COMPLETED